These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
23. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM. Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332 [Abstract] [Full Text] [Related]
24. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
25. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Wendel S, Levi JE, Biagini S, Candotti D, Allain JP. Transfusion; 2008 Aug; 48(8):1602-8. PubMed ID: 18466175 [Abstract] [Full Text] [Related]
26. Occult hepatitis B virus infection: detection and significance. Gerlich WH, Bremer C, Saniewski M, Schüttler CG, Wend UC, Willems WR, Glebe D. Dig Dis; 2010 Aug; 28(1):116-25. PubMed ID: 20460899 [Abstract] [Full Text] [Related]
27. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Allain JP. Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876 [Abstract] [Full Text] [Related]
28. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793 [Abstract] [Full Text] [Related]
29. Hepatitis B virus blood screening: impact of nucleic amplification technology testing implementation on identifying hepatitis B surface antigen non-reactive window period and chronic infections. Iudicone P, Miceli M, Palange M, Agresti A, Gallo A, Isacchi G, Girolami E, Pierelli L, Mannella E. Vox Sang; 2009 May; 96(4):292-7. PubMed ID: 20701733 [Abstract] [Full Text] [Related]
30. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection. Satoh K, Iwata-Takakura A, Yoshikawa A, Gotanda Y, Tanaka T, Yamaguchi T, Mizoguchi H. Vox Sang; 2008 Oct; 95(3):174-80. PubMed ID: 19121181 [Abstract] [Full Text] [Related]
31. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185 [Abstract] [Full Text] [Related]
32. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, Reddy R, Crookes R, Kramvis A. Transfusion; 2012 Apr; 52(4):880-92. PubMed ID: 21981386 [Abstract] [Full Text] [Related]
33. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. Coppola N, Loquercio G, Tonziello G, Azzaro R, Pisaturo M, Di Costanzo G, Starace M, Pasquale G, Cacciapuoti C, Petruzziello A. J Clin Virol; 2013 Sep; 58(1):315-7. PubMed ID: 23856167 [Abstract] [Full Text] [Related]
34. Hepatitis B virus blood screening: unfinished agendas. Comanor L, Holland P. Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595 [Abstract] [Full Text] [Related]
35. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. Awerkiew S, Däumer M, Reiser M, Wend UC, Pfister H, Kaiser R, Willems WR, Gerlich WH. J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939 [Abstract] [Full Text] [Related]
36. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related]
37. [Investigation of HBV-DNA using the polymerase chain reaction (PCR) in HBsAg-negative, anti-HBc-positive Venezuelan donors]. León G, López JL, Maio A, García L, Quiroz AM. Sangre (Barc); 1999 Oct; 44(5):342-6. PubMed ID: 10618910 [Abstract] [Full Text] [Related]
38. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053 [Abstract] [Full Text] [Related]
39. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
40. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK. J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]